No Data
No Data
No Data
No Data
No Data
[Broker Focus] CMB International expects China's pharmaceutical industry to return to healthy growth this year
Jinwu Financial News | CMB International said that since the beginning of the year, the MSCI China Healthcare Index has fallen 22.7%, outperforming the MSCI China Index by 23.3%. Looking ahead to 2024, China's pharmaceutical industry is expected to return to healthy growth as industry regulation is normalized and the impact of the COVID-19 base gradually subsides. The bank continues to be optimistic about BeiGene (06160), Cinda Biotech (01801), Columbotai (06990), Giant Biotech (02367), Gushengtang (02273), and Mindray Healthcare (300760). Additionally, it is recommended to focus on high-dividend stocks with steady performance, such as Regal Healthcare
金吾財訊Apr 16 02:51 ET
Livzon Pharmaceuticals (01513.HK) plans to hold a board meeting on April 23 to approve quarterly results
Gelonghui, April 11, 丨 Lizhu Pharmaceutical (01513.HK) issued an announcement. The board of directors hereby announces that it will hold a board meeting on April 23, 2024 (Tuesday) to review and approve the unaudited quarterly results of the company and its subsidiaries for the three months ended March 31, 2024, and to deal with other matters.
Gelonghui FinanceApr 11 04:45 ET
Livzon Pharmaceutical Group (SZSE:000513) Shareholders Have Earned a 11% CAGR Over the Last Five Years
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For exa
Simply Wall StApr 5 18:46 ET
Pearl Group (000513.SZ) has repurchased a total of 2.152,600 A-share shares at a cost of 73.436,500 yuan
Pearl Group (000513.SZ) issued an announcement. As of March 31, 2024, the company passed centralized bidding...
Zhitong FinanceApr 2 05:20 ET
Pearl Pharmaceuticals (01513) plans to renew its employment with Tong Certified Public Accountants
Lizhu Pharmaceutical (01513) announced that the company plans to renew the employment of Certified Public Accountants (Special General Partnership) as the company...
Zhitong FinanceMar 28 11:19 ET
Livzon Pharmaceuticals (01513) released annual results, net profit of 1,954 billion yuan, an increase of 2.32% year-on-year
Livestock Pharmaceuticals (01513) announced the audited results for the year ended December 31, 2023. During the period...
Zhitong FinanceMar 28 11:02 ET
No Data
No Data